Skip to main content
Top
Published in:

03-01-2024 | Geriatric Assessment

Strategies to Assess and Manage Frailty among Patients Diagnosed with Primary Malignant Brain Tumors

Authors: Alayna E. Ernster, PhD, Heidi D. Klepin, MD, MS, Glenn J. Lesser, MD

Published in: Current Treatment Options in Oncology | Issue 1/2024

Login to get access

Opinion statement

Frailty refers to a biologic process that results in reduced physiologic and functional reserve. Patients diagnosed with primary malignant brain tumors experience high symptom burden from tumor and tumor-directed treatments that, coupled with previous comorbidities, may contribute to frailty. Within the primary malignant brain tumor population, frailty is known to associate with mortality, higher healthcare utilization, and increased risk of postoperative complications. As such, methods to assess and manage frailty are paramount. However, there is currently no clear consensus on how to best assess and manage frailty throughout the entirety of the disease trajectory. Given the association between frailty and health outcomes, more research is needed to determine best practice protocols for the assessment and management of frailty among patients diagnosed with primary malignant brain tumors.
Literature
8.
go back to reference •• Dale W, Klepin HD, Williams GR, Alibhai SMH, Bergerot C, Brintzenhofeszoc K, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol. 2023;41(26):4293–312. https://doi.org/10.1200/jco.23.00933. ASCO report that outlines geriatric assessment tools and the outcomes from randomized controlled trials that assessed the efficacy geriatric-assessment informed management interventions.CrossRefPubMed •• Dale W, Klepin HD, Williams GR, Alibhai SMH, Bergerot C, Brintzenhofeszoc K, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol. 2023;41(26):4293–312. https://​doi.​org/​10.​1200/​jco.​23.​00933. ASCO report that outlines geriatric assessment tools and the outcomes from randomized controlled trials that assessed the efficacy geriatric-assessment informed management interventions.CrossRefPubMed
9.
go back to reference Dale W, Williams GR, A RM, Soto-Perez-de-Celis E, Maggiore RJ, Merrill JK, et al. How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology. JCO Oncol Pract. 2021;17(6):336-44. https://doi.org/10.1200/op.20.00442. Dale W, Williams GR, A RM, Soto-Perez-de-Celis E, Maggiore RJ, Merrill JK, et al. How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology. JCO Oncol Pract. 2021;17(6):336-44. https://​doi.​org/​10.​1200/​op.​20.​00442.
30.
go back to reference • Thommen R, Kazim SF, Rumalla K, Kassicieh AJ, Kalakoti P, Schmidt MH, et al. Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis. J Neurooncol. 2022;160(2):285–97. https://doi.org/10.1007/s11060-022-04135-z. Compared the predictive utility of the modified frailty index and risk analysis index among a sample of neuro-oncology patients.CrossRefPubMed • Thommen R, Kazim SF, Rumalla K, Kassicieh AJ, Kalakoti P, Schmidt MH, et al. Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis. J Neurooncol. 2022;160(2):285–97. https://​doi.​org/​10.​1007/​s11060-022-04135-z. Compared the predictive utility of the modified frailty index and risk analysis index among a sample of neuro-oncology patients.CrossRefPubMed
33.
go back to reference • Huq S, Liu J, Romano R, Seal S, Khalafallah AM, Walston JD, et al. Frailty in patients undergoing surgery for brain tumors: a systematic review of the literature. World Neurosurg. 2022;166:268-78.e8. https://doi.org/10.1016/j.wneu.2022.07.039. Review that provides an overview of frailty screening tools used within neuro-oncology populations and outlines individual study results.CrossRefPubMed • Huq S, Liu J, Romano R, Seal S, Khalafallah AM, Walston JD, et al. Frailty in patients undergoing surgery for brain tumors: a systematic review of the literature. World Neurosurg. 2022;166:268-78.e8. https://​doi.​org/​10.​1016/​j.​wneu.​2022.​07.​039. Review that provides an overview of frailty screening tools used within neuro-oncology populations and outlines individual study results.CrossRefPubMed
48.
go back to reference •• Lorimer CF, Walsh G, MacKinnon M, Corbett A, Bedborough K, Greenwood K, et al. Geriatric assessment of glioblastoma patients is feasible and may provide useful prognostic information. Neurooncol Pract. 2020;7(2):176–84. https://doi.org/10.1093/nop/npz040. Prospective study that demonstrated the feasibility of geriatric assessment for patients diagnosed with glioblastoma.CrossRefPubMed •• Lorimer CF, Walsh G, MacKinnon M, Corbett A, Bedborough K, Greenwood K, et al. Geriatric assessment of glioblastoma patients is feasible and may provide useful prognostic information. Neurooncol Pract. 2020;7(2):176–84. https://​doi.​org/​10.​1093/​nop/​npz040. Prospective study that demonstrated the feasibility of geriatric assessment for patients diagnosed with glioblastoma.CrossRefPubMed
49.
go back to reference •• Lombardi G, Bergo E, Caccese M, Padovan M, Bellu L, Brunello A, et al. Validation of the comprehensive geriatric assessment as a predictor of mortality in elderly glioblastoma patients. Cancers (Basel). 2019;11(10). https://doi.org/10.3390/cancers11101509. Demonstrated the prognostic value of comprehensive geriatric assessment for older adult patients diagnosed with glioblastoma. •• Lombardi G, Bergo E, Caccese M, Padovan M, Bellu L, Brunello A, et al. Validation of the comprehensive geriatric assessment as a predictor of mortality in elderly glioblastoma patients. Cancers (Basel). 2019;11(10). https://​doi.​org/​10.​3390/​cancers11101509. Demonstrated the prognostic value of comprehensive geriatric assessment for older adult patients diagnosed with glioblastoma.
50.
go back to reference •• Mohile SG, Mohamed MR, Xu H, Culakova E, Loh KP, Magnuson A, et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet. 2021;398(10314):1894–904. https://doi.org/10.1016/S0140-6736(21)01789-X. Randomized controlled trial of geriatric assessment-informed management intervention. •• Mohile SG, Mohamed MR, Xu H, Culakova E, Loh KP, Magnuson A, et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet. 2021;398(10314):1894–904. https://​doi.​org/​10.​1016/​S0140-6736(21)01789-X. Randomized controlled trial of geriatric assessment-informed management intervention.
51.
go back to reference •• Li D, Sun C-L, Kim H, Soto-Perez-de-Celis E, Chung V, Koczywas M, et al. Geriatric assessment–driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial. JAMA Oncology. 2021;7(11):e214158-e. https://doi.org/10.1001/jamaoncol.2021.4158 . Randomized controlled trial of geriatric assessment-informed management intervention. •• Li D, Sun C-L, Kim H, Soto-Perez-de-Celis E, Chung V, Koczywas M, et al. Geriatric assessment–driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial. JAMA Oncology. 2021;7(11):e214158-e. https://​doi.​org/​10.​1001/​jamaoncol.​2021.​4158 .  Randomized controlled trial of geriatric assessment-informed management intervention.
Metadata
Title
Strategies to Assess and Manage Frailty among Patients Diagnosed with Primary Malignant Brain Tumors
Authors
Alayna E. Ernster, PhD
Heidi D. Klepin, MD, MS
Glenn J. Lesser, MD
Publication date
03-01-2024
Publisher
Springer US
Published in
Current Treatment Options in Oncology / Issue 1/2024
Print ISSN: 1527-2729
Electronic ISSN: 1534-6277
DOI
https://doi.org/10.1007/s11864-023-01167-z

ASH 2024 Annual Meeting Coverage

inMIND supports tafasitamab addition in follicular lymphoma

Combining tafasitamab with lenalidomide and rituximab significantly improves progression-free survival for patients with relapsed or refractory follicular lymphoma.

Featuring the official presentation video

Read more
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now